1-(3-[18F]fluoropropyl)piperazines as model compounds for the radiofluorination of pyrido[2,3-d]pyrimidines

Radiochimica Acta

Volumn 99, Issue 6, 2011, Pages 365-373

  Grosse Gehling, P ^a   Wuest, F R ^b   Peppel, T ^c   Kockerling M ^c   Mamat, C ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

CDK inhibitor; Pyrido 2,3 d pyrimidines; Radiofluorination; Spiro compounds

Indexed keywords

EID: 79957686070     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1834     Document Type: Article

References (35)

1. Deshpande, A., Sicinski, P., Hinds, P. W.: Cyclins and CDKs in development and cancer: a perspective. Oncogene 24, 2909 (2005).
2. Fry, D. W., Bedford, D. C., Harvey, P. H., Fritsch, A., Keller, P. R., Wu, Z. P., Dobrusin, E., Leopold, W. R., Fattaey, A., Garret, M. D.: Cell cycle and biochemical effects of PD 0183812: a potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6. J. Biol. Chem. 276, 16617 (2001).
3. Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M. A., Trachet, E., Albassam, M., Zheng, X. X., Leopold, W. R., Pryer, N. K., Toogood, P. L.: Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol. Cancer Ther. 3, 1427 (2004).
4. VanderWel, S. N., Harvey, P. J., McNamara, D. J., Repine, J. T., Keller, P. R., Quin, J., Booth, R. J., Elliott, W. L., Dobrusin, E. M., Fry, D. W., Toogood, P. L.: Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4. J. Med. Chem. 48, 2371 (2005).
5. Graf, F., Koehler, L., Kniess, T., Wuest, F., Mosch, B., Pietzsch, J.: Cell cycle regulating kinase Cdk4 as a potential target for tumor cell treatment and tumor imaging. J. Oncol. (2009) doi:10.1155/2009/106378.
6. Koehler, L., Graf, F., Bergmann, R., Steinbach, J., Pietzsch, J., Wuest, F.: Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors. Eur. J. Med. Chem. 45, 727 (2010).
7. Lu, H., Schulze-Gahmen, U.: Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition. J. Med. Chem. 49, 3826 (2006).
8. 18F]β-fluoroethyl tosylate under microwave-enhanced conditions. J. Labelled Compd. Radiopharm. 47, 289 (2004).
9. Cai, L., Chin, F. T., Pike, V. W., Toyama, H. Liow, J.-S., Zoghbi, S. S., Modell, K., Briard, E., Shetty, H. U., Sinclair, K., Donohue, S., Tipre, D., Kung, M. P., Dagostin, C., Widdowson, D. A., Green, M., Gao, W., Herman, M. M., Ichise, M., Innis, R. B.: Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino) phenylimidazo[1,2-α]pyridine derivatives as prospective radioligands for β-amyloid in alzheimer's disease. J. Med. Chem. 47, 2208 (2004).
10. 11C]β-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET). J. Labelled Compd. Radiopharm. 43, 1235 (2000).
11. 18F]fluoropropyl tosylate as the labelling reagent. J. Labelled Compd. Radiopharm. 48, 463 (2005).
12. 18F] Fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography. J. Med. Chem. 33, 1482 (1990).
13. 18F]FP-β-CIT). J. Labelled Compd. Radiopharm. 49, 77 (2006).
14. 18F-Labelled metomidate analogues as adrenocortical imaging agents. Nucl. Med. Biol. 36, 435 (2009).
15. 18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)-piperidine: A potential sigma-1 receptor radioligand for PET. J. Labelled Compd. Radiopharm. 38, 785 (1996).
16. 18F]fluoroalkyl-2- nitroimidazoles for imaging hypoxia. Biol. Pharm. Bull. 22, 590 (1999).
17. 18F]fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D2 receptors. Chem. Pharm. Bull. 40, 1793 (1992).
18. 18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent. Biol. Pharm. Bull. 25, 616 (2002).
19. 18F]CPFPX): A potent and selective a1-adenosine receptor antagonist for in vivo imaging. J. Med. Chem. 45, 5150 (2002).
20. 18F-labelling of radiopharmaceuticals. J. Labelled Compd. Radiopharm. 46, 959 (2003).
21. 2 nicotinic acetylcholine receptor radioligand for PET. J. Labelled Compd. Radiopharm. 46, 1261 (2003).
22. N2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules. J. Am. Chem. Soc. 128, 16394 (2006).
23. Moore, J. A., Ayers, R. S.: The Chemistry of Heterocyclic Compounds. Vol. 42, John Wiley & Sons, New York (1983), pp. 1-218.
24. Couty, F., David, O., Drouillat, B.: Opening of azetidinium ions with C-nucleophiles. Tetrahedron Lett. 48, 9180 (2007).
25. Cospito, G., Illuminati, G., Lillocci, C., Petride, H.: Ring-opening reactions. 3. Mechanistic path vs. ring-strain control in elimination and substitution reactions of 1,1-dimethyl cyclic ammonium ions and their α,α'-dimethyl-substituted derivatives. J. Org. Chem. 46, 2944 (1981).
26. 2-agonists. Eur. J. Med. Chem. 23, 295 (1988).
27. 18F]fluoropropyl amines. J. Labelled Compd. Radiopharm. 47, 953 (2004).
28. Swanson, D. M., Dubin, A. E., Shah, C., Nasser, N., Chang, L., Dax, S. L., Jetter,M., Breitenbucher, J. G., Liu, C., Mazur, C., Lord, B., Gonzales, L., Hoey, K., Rizzolio, M., Bogenstaetter, M., Codd, E. E., Lee, D. H., Zhang, S.-P., Chaplan, S. R., Carruthers, N. I.: Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J. Med. Chem. 48, 1857 (2005).
29. Erhardt, P. W., Owens, A. H.: Facile formation of quaternary azetidinium compounds during triflation of dialkylaminopropanols. Synth. Commun. 17, 469 (1987).
30. Kim, D. W., Jeong, H.-J., Lim, S. T., Sohn, M.-H., Katzenellenbogen, J. A., Chi, D. Y.: Facile nucleophilic fluorination reactions using tert-alcohols as a reaction medium: significantly enhanced reactivity of alkali metal fluorides and improved selectivity. J. Org. Chem. 73, 957 (2008).
31. Leonard, N. J., Ning, R. Y., Booth, R. L.: Small charged rings. VIII. Isolation and stereochemistry of acyl aziridinium salt intermediates. J. Org. Chem. 30, 4357 (1965).
32. Huh, N., Thompson, C. M.: Enantioenriched N-(2-chloroalkyl)-3- acetoxypiperidines as potential cholinotoxic agents. synthesis and preliminary evidence for spirocyclic aziridinium formation. Tetrahedron 51, 5935 (1995).
33. Leonard, N. J., Paukstelis, J. V.: Small charged rings. VII. Interconversion of substituted β-chloroethylamines and aziridinium salts. J. Org. Chem. 30, 821 (1965).
34. Sheldrick, G.M.: SHELXS-97 and SHELXL-97, Programs for the solution and refinement of crystal structures, University of Göttingen (1997).
35. Sheldrick, G. M.: A short history of SHELX. Acta. Cryst. A 64, 112 (2008).